Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.76% | 195.47 | 1.3% | $555.99m | |
| GILD | Gilead Sciences, Inc. | 0.24% | 66.52 | 0.9% | $368.70m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.79% | 107.40 | 2.0% | $321.44m | |
| ILMN | Illumina, Inc. | 1.14% | 300.91 | 3.5% | $301.00m | |
| BIIB | Biogen Inc. | 1.86% | 236.63 | 1.3% | $288.49m | |
| CELG | Celgene Corporation | -0.23% | 98.40 | 1.3% | $282.90m | |
| A | Agilent Technologies, Inc. | 0.43% | 77.90 | 1.6% | $193.04m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.25% | 86.00 | 14.7% | $180.31m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.44% | 174.94 | 1.9% | $173.66m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.90% | 281.62 | 2.6% | $171.53m | |
| EXAS | Exact Sciences Corporation | -1.82% | 106.71 | 24.1% | $132.03m | |
| ACAD | ACADIA Pharmaceuticals Inc. | 3.35% | 40.45 | 13.9% | $98.63m | |
| INCY | Incyte Corporation | 0.47% | 76.43 | 2.5% | $83.43m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.21% | 72.65 | 4.3% | $76.16m | |
| IONS | Ionis Pharmaceuticals, Inc. | -1.02% | 66.20 | 8.2% | $63.42m |
Company Profile
Illumina, Inc. engages in the development and manufacture of integrated systems for the analysis of genetic variation and function. It operates through the Core Illumina and Consolidated Variable Interest Entity segments (VIE). The Core Illumina segments serve customers in the research, clinical and applied markets, and enable the adoption of genomic solutions. The Consolidated VIE segment includes activities of GRAIL and Helix. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.